Opus Genetics IRD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$65.54M-297% | -$16.52M+5.3% | -$17.45M-135% | -$7.42M+9.4% | -$8.19M+76.7% | ||
| $13K0.0% | $13K0.0% | $13K-7.1% | $14K+7.7% | $13K+30.0% | ||
| $1.46M+89.1% | $774K-5.1% | $816K-8.9% | $896K-1.9% | $913K+14.8% | ||
| -$264K+71.3% | -$921K-90.7% | -$483K— | —— | -$483K-128% | ||
| $1.16M+43.7% | $804K-11.3% | $906K+192% | -$985K-37.2% | -$718K-147% | ||
| $432K+149% | -$873K+7.7% | -$946K+51.4% | -$1.95M-816% | $272K-88.4% | ||
| $2.14M+120% | $973K— | —— | $53K-93.9% | $865K— | ||
| $0— | —— | —— | -$1K0.0% | -$1K0.0% | ||
| -$12.73M-29.4% | -$9.83M-59.7% | -$6.16M+40.0% | -$10.27M-14.2% | -$8.99M-20.9% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $0— | $0— | $0— | $0— | $0-100% | ||
| $2.25M+1,157% | $179K-96.6% | $5.22M— | $0-100% | $409K— | ||
| $25M— | —— | —— | —— | $0— | ||
| $27.6M+14.5% | $24.11M+431% | $4.54M+401% | $906K-95.6% | $20.47M— | ||
| $14.87M+4.1% | $14.28M— | —— | —— | $11.47M+282% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $13K0.0% | $13K0.0% | $13K-7.1% | $14K+7.7% | $13K+30.0% | ||
| -$51.36M-799% | -$5.71M+40.0% | -$9.53M-1,139% | $917K-67.3% | $2.81M+3,796% | ||
| $432K+149% | -$873K+7.7% | -$946K+51.4% | -$1.95M-816% | $272K-88.4% | ||
| -$186K+4.1% | -$194K— | —— | -$497K+6.9% | -$534K-172% | ||
| $2.14M+120% | $973K— | —— | $53K-93.9% | $865K— | ||
| —— | $14.25K0.0% | $14.25K0.0% | $14.25K0.0% | $14.25K— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $0— | —— | —— | —— | $1.37M— | ||
| —— | $98K-85.9% | $696K+640% | $94K-93.3% | $1.41M+2,972% | ||
| —— | $5.75M0.0% | $5.75M0.0% | $5.75M0.0% | $5.75M— | ||
| $0— | —— | —— | —— | $5.98M— | ||
| $0— | —— | —— | —— | $15.52M— | ||
| $33K-71.6% | $116K— | —— | —— | $36K-2.7% | ||
| $69K+13.1% | $61K-10.3% | $68K— | $0— | $0— | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| —— | $263K0.0% | $263K0.0% | $263K0.0% | $263K— | ||
| $0— | —— | —— | -$1K0.0% | -$1K0.0% | ||
| $0— | $0— | $0— | $0— | $0— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Opus Genetics generate?
- Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
- Where does Opus Genetics's cash flow data come from?
- Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
